Multiple sclerosis is a highly variable disorder that usually presents with recurrent, painless episodes of neurologic symptoms at 15 to 50 years of age.
Multiple Sclerosis Community Forum
Support for patients with multiple sclerosis and related neurological disorders. Discussions among patients, families, caregivers and professionals on topics related to diagnosis, treatment, and activities of daily living.
Panel outlines new diagnostic criteria for neuromyelitis optica
Jul 09, 2015
New diagnostic criteria were introduced this week for neuromyelitis optica, now called neuromyelitis optica spectrum disorder (NMOSD)—an inflammatory disease of the CNS that is sometimes mistaken for multiple sclerosis. An international consensus panel reviewed the medical literature and recent scientific discoveries relating to NMOSD to develop new diagnostic criteria.
Study reveals brain network responsible for cognitive changes in multiple sclerosis
Jul 08, 2015
New findings published yesterday in Neuropsychology reveal that decreased connectivity between the dorsolateral prefrontal cortex and posterior brain regions are to blame for the central deficit common to the various cognitive changes associated with multiple sclerosis—slowed cognitive speed.
Discovery of a treatment to block the progression of multiple sclerosis
May 19, 2015
A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and significantly slow its progression. These encouraging results from in vitro tests in humans and in vivo tests in mice were published today in the Annals of Neurology.
Study implicates new gene in multiple sclerosis disease activity
May 15, 2015
A new study led by investigators at Brigham and Women's Hospital reports the discovery of a genetic variant that is associated with a patient's likelihood of responding to interferon-beta. Published in the Annals of Neurology on May 14, the study also presents evidence that the affected gene, SLC9A9, may have a broader role in regulating the development and activity of certain immune cells that play important roles in inflammatory diseases like multiple sclerosis.
Cytokine may play major role in multiple sclerosis
Apr 30, 2015
A study published online April 27th, in the Journal of Immunology, confirms that the cytokine GM-CSF (granulocyte macrophage colony-stimulating factor) likely plays an important role in human disease and offers a new explanation for why the multiple sclerosis treatment interferon-Beta (INF-ß) is often effective at reducing multiple sclerosis attacks.
New anti-inflammatory molecule could halt multiple sclerosis progression
Mar 16, 2015
Scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis. The small drug-like molecule is called WEHI-345. It binds to and inhibits a key immune signaling protein called RIPK2, which prevents the release of inflammatory cytokines.
A real eye-opener: narcolepsy bears classic autoimmune hallmarks
Mar 09, 2015
A new study published in Pharmacological Research finds that narcolepsy bears the trademarks of a classic autoimmune disorder and should be treated accordingly. The research points to a particular autoimmune process as the trigger for the specific loss of orexin neurons, which maintain the delicate equilibrium between sleep and wakefulness in the brain
Stem cell transplantation shows potential for reducing disability in multiple sclerosis patients
Jan 20, 2015
Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis, treatment with nonmyeloablative hematopoietic stem cell transplantation (low intensity stem cell transplantation) was associated with improvement in measures of disability and quality of life, according to a study in the January 20 issue of JAMA.